Correlation Between SAB Biotherapeutics and Roivant Sciences
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Roivant Sciences, you can compare the effects of market volatilities on SAB Biotherapeutics and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Roivant Sciences.
Diversification Opportunities for SAB Biotherapeutics and Roivant Sciences
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between SAB and Roivant is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Roivant Sciences go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Roivant Sciences
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 19.99 times more return on investment than Roivant Sciences. However, SAB Biotherapeutics is 19.99 times more volatile than Roivant Sciences. It trades about 0.12 of its potential returns per unit of risk. Roivant Sciences is currently generating about 0.14 per unit of risk. If you would invest 13.00 in SAB Biotherapeutics on September 4, 2024 and sell it today you would lose (7.83) from holding SAB Biotherapeutics or give up 60.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 10.87% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Roivant Sciences
Performance |
| Timeline |
| SAB Biotherapeutics |
| Roivant Sciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
SAB Biotherapeutics and Roivant Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Roivant Sciences
The main advantage of trading using opposite SAB Biotherapeutics and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
| Roivant Sciences vs. Roivant Sciences | Roivant Sciences vs. Jasper Therapeutics | Roivant Sciences vs. Humacyte | Roivant Sciences vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |